COMMUNIQUÉS West-GlobeNewswire

Uptick Newswire “Stock Day” Interviews CEO of Lexaria on Cannabis Related Products and Recent Bioscience Patents

18/12/2017 - 14:00

Phoenix, AZ, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire is the sole producer of the Uptick Network “Stock Day” Podcast and after airing back in January 2016 CEO and host Everett Jolly has interviewed hundreds of [...]

Samumed Doses First Patient in Phase 1 Trial of SM04690 for Treatment of Degenerative Disc Disease

18/12/2017 - 14:00

SAN DIEGO, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Samumed, LLC, today announced the dosing of the first degenerative disc disease (DDD) patient in its Phase 1 trial of SM04690, a small molecule Wnt pathway inhibitor [...]

CytomX Therapeutics Added to NASDAQ Biotechnology Index

18/12/2017 - 14:00

SOUTH SAN FRANCISCO, Calif., Dec. 18, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX ), a clinical-stage biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of [...]

Aduro Biotech Announces the Initiation of a Phase 1/2 Clinical Trial of BION-1301, a Novel Anti-APRIL Antibody, for the Treatment of Multiple Myeloma

18/12/2017 - 14:00

BERKELEY, Calif., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq: ADRO ), a biopharmaceutical company with three distinct immunotherapy technologies, today announced that the first patient in its Phase 1/ [...]

Opiant Pharmaceuticals Announces Publication of New Pre-Clinical Data Supporting Potential of OPNT005 as a Heroin Vaccine

18/12/2017 - 14:00

Data Published Online in Journal of Medicinal Chemistry Company Evaluating Potential Clinical Program for OPNT005 SANTA MONICA, Calif., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: [...]

Athenex, Inc. Added to Nasdaq Biotechnology Index

18/12/2017 - 14:00

BUFFALO, N.Y., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Biotricity Achieves FDA 510(k) Clearance for its Bioflux Device

18/12/2017 - 14:00

REDWOOD CITY, Calif., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]

Pain Therapeutics Reports Positive Regulatory Meeting for REMOXY™

18/12/2017 - 14:00

AUSTIN, Texas, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE ), a biopharmaceutical company, today announced that it has successfully concluded a regulatory meeting with the U.S. Food and Drug [...]

Interpace Diagnostics Announces Agreement with ARUP Laboratories

18/12/2017 - 14:00

PARSIPPANY, N.J., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically useful molecular [...]

Catalyst Biosciences Announces Acceleration of Phase 1/2 Trial of CB 2679d/ISU304 in Individuals with Hemophilia B

18/12/2017 - 14:00

Korean Ministry of Food and Drug Safety Approves Omitting Cohort 4 and Dosing Cohort 5 with Six Daily Subcutaneous Doses of Next-Generation Coagulation Factor IX Current lower doses are predicted to achieve normal [...]

Arch Therapeutics Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA

18/12/2017 - 13:50

FRAMINGHAM, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced that the [...]

EDAP's Focal One® Robotic HIFU Treatments Performed at Acibadem Hospital, Istanbul, Turkey

18/12/2017 - 13:30

LYON, France, December 18, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the first HIFU treatments performed at Acibadem Hospital, Istanbul, Turkey, using the Company's [...]

ICU Medical, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference

18/12/2017 - 13:30

SAN CLEMENTE, Calif., Dec. 18, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI ), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]

REPEAT – Cannabis Wheaton Income Corp. Announces Sustainable Growth Strategic Capital Corp. as New Wheaton Streaming Partner

18/12/2017 - 13:30

VANCOUVER, British Columbia, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or the " Company ") is pleased to announce that it has entered into a [...]

Kura Oncology Added to Nasdaq Biotechnology Index

18/12/2017 - 13:30

SAN DIEGO, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it has [...]

Innovation Pharmaceuticals Brilacidin Oral Mucositis Program Moving Forward Based Upon Positive Anchoring Phase 2 Results and Increased Brilacidin Franchise Value

18/12/2017 - 13:30

BEVERLY, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today is pleased to provide an update on the developmental plan for [...]

Intellia Therapeutics Names John Leonard, M.D., President and Chief Executive Officer

18/12/2017 - 13:30

Dr. Leonard has successfully led the development and regulatory approval of breakthrough biopharmaceuticals Company’s pipeline continues to advance toward clinical development CAMBRIDGE, Mass., Dec. 18, 2017 (GLOBE [...]

Major shareholder announcement

18/12/2017 - 13:08

Orphazyme A/S Company announcement No. 17/2017 Major shareholder announcement Copenhagen, December 18, 2017 – With reference to company announcement no. 5/2017 dated November 16, 2017 regarding the result of the Initial [...]

Sanofi and Alnylam submit Marketing Authorization Application to the European Medicines Agency for patisiran for the treatment of hereditary ATTR amyloidosis

18/12/2017 - 13:01

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Alnylam submit Marketing Authorization Application to the European Medicines Agency for patisiran for the treatment of hereditary ATTR amyloidosis [...]